EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Approach for the Synthesis of Peripherally Acting Dual Target Inhibitor of Cannabinoid-1 (CB1 Receptor) and Inducible Nitric Oxide Synthase (iNOS) (S-MRI-1867/Zevaquenabant)

Malliga R Iyer iD

Molecules · 2026

DOI: 10.3390/molecules31030515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Malliga R Iyer. Beteiligte Einrichtung: Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD 2…. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Nitric Oxide Synthase Type II. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zevaquenabant (S-MRI-1867) is a clinical-stage agent that is a peripherally restricted, potent antagonist of CB1R and an inhibitor of inducible nitric oxide synthase. A novel synthetic route to this highly selective active pharmaceutical agent is described in this paper. This route makes use of rationally installed chiral thio-substituted leaving group derived from a Bunte-salt reaction approach to yield diastereomeric compounds which are further processed to enantiopure compounds. The method will enable a rapid assembly of a variety of chiral sulfonyl amino compounds in this series.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1Nitric Oxide Synthase Type IIHumansMolecular StructureStereoisomerismPyrazolesSulfur Compounds

Stichwörter der Autor:innen

CB1R CB2RECSMASHMPOPSASFCiNOS

Substanzen

Receptor, Cannabinoid, CB1Nitric Oxide Synthase Type IIMRI-1867PyrazolesSulfur Compounds

Autor:innen und Institutionen

  • Section on Medicinal Chemistry, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Rockville, MD 20852, USA.

ORCID-Profile: Malliga R Iyer

Förderung

  • Intramural NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Iyer, M. R. (2026). A Novel Approach for the Synthesis of Peripherally Acting Dual Target Inhibitor of Cannabinoid-1 (CB1 Receptor) and Inducible Nitric Oxide Synthase (iNOS) (S-MRI-1867/Zevaquenabant). Molecules. https://doi.org/10.3390/molecules31030515

Vancouver

Iyer MR. A Novel Approach for the Synthesis of Peripherally Acting Dual Target Inhibitor of Cannabinoid-1 (CB1 Receptor) and Inducible Nitric Oxide Synthase (iNOS) (S-MRI-1867/Zevaquenabant). Molecules. 2026. doi:10.3390/molecules31030515

BibTeX
@article{Iyer2026,
  author = {Iyer, Malliga R},
  title = {A Novel Approach for the Synthesis of Peripherally Acting Dual Target Inhibitor of Cannabinoid-1 (CB1 Receptor) and Inducible Nitric Oxide Synthase (iNOS) (S-MRI-1867/Zevaquenabant)},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31030515}
}
Kostenlos starten →